Principală  —  About Moldova   —   The Pfizer, AstraZeneca, and Sputnik-V…

The Pfizer, AstraZeneca, and Sputnik-V Vaccines Officially Authorized in Moldova

The Medicines and Medical Devices Agency authorized the Pfizer-BioNTech and AstraZeneca vaccines, as well as the Gam-COVID-Vac (Sputnik V) vaccine, to prevent the coronavirus infection.

“On February 26, we decided to conditionally authorize the vaccines used in the prevention of COVID-19, issuing a Certificate of Registration within one year and requesting the submission of post-authorization safety studies and post-authorization efficacy studies. We conditionally authorized the vaccines included by the World Health Organization in the Emergency Use Listing: Pfizer / BioNTech and AstraZeneca, but also the Gam-COVID-Vac (Sputnik V) vaccine, to prevent coronavirus infection. The conditional authorization of vaccines creates the opportunity to initiate the immunization of the population,” announced the institution.

The Socialist Party’s leader Igor Dodon announced the Russian vaccine’s authorization too.

“A few minutes ago, the Russian vaccine against Coronavirus, Sputnik-V, was officially registered in Moldova. Deliveries will start very soon! Our population will get access to the vaccine that is used in about 40 countries around the world, including the European ones, and is considered by experts to be safe and highly effective. I express my sincere gratitude to the Russian partners for their openness and willingness to provide assistance to Moldova and its citizens,” said Dodon.


The Medicines and Medical Devices Agency announced on February 16 that it is in the process of authorizing anti-COVID-19 vaccines manufactured by Pfizer-BioNTech, AstraZeneca, and Moderna, which are included in the COVAX program. At the same time, they announced that they received 2 files for the authorization of the Russian Sputnik V vaccine, which is not authorized by the World Health Organization.

“The aim is to make medicines, vaccines, and diagnosis available as soon as possible in order to address the emergency situation while respecting strict safety, efficacy, and quality criteria. The threat posed by the emergency is assessed, as well as the benefits that would result from the use of the medicinal product, including vaccines against any potential risks,” the Medicines and Medical Devices Agency representatives claimed.

Îți mulțumim că citești ZdG.md!

Oferim în continuare informații gratuite tuturor, dar cu susținerea cititorilor noștri am putea reuși să facem mai multe investigații, știri, reportaje, editoriale, texte explicative, materiale video și alte produse jurnalistice de interes public.

Susține dezvoltarea jurnalismului de investigație cu o donație prin MIA Plăți Instant, scanând codul QR alăturat.



Pentru mai multe opțiuni de a dona, precum și pentru a perfecta un abonament la ediția tipărită a Ziarului de Gardă, accesați ZdG.one

Dacă doriți să cunoașteți cât costă și cine plătește ZdG — vedeți sursele de finanțare ale ZdG.

Publicitate1